Home › Funds › Leonteq Securities AG › MRNA

Leonteq Securities AG position in MRNA

MODERNA INC · Health Care

Leonteq Securities AG reported holding 152,218 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$29.3M, representing 3.02% of its reported portfolio and ranking #3 among its reported holdings. Leonteq Securities AG has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)152.22K sh
Reported value held$29.31M
Portfolio Weight3.02%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Leonteq Securities AG's MRNA position evolved

Leonteq Securities AG first disclosed a stake in MRNA in Q3 2023 at 85,900 shares (US$8.9M). The position peaked in Q3 2026 at 152,218 shares, worth US$29.3M. Across 13 filings, Leonteq Securities AG increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 152,218 shares valued at US$29.3M — a reduction of -114,913 shares quarter over quarter.. Notable position changes include a 7176% increase in Q1 2025 (shares fell 3% over the following quarter), a 97% trim in Q4 2025 (shares rose 72% over the following quarter), a 1471% increase in Q2 2026 (shares rose 175% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 85.90K $8.87M New
Q4 2023 50.63K $5.03M Reduce
Q1 2024 18.80K $2.00M Reduce
Q2 2024 6.00K $712.50K Reduce
Q3 2024 6.00K $400.98K Hold
Q4 2024 6.00K $249.48K Hold
Q1 2025 436.57K $12.37M Add
Q2 2025 533.33K $14.71M Add
Q3 2025 540.13K $13.95M Add
Q4 2025 17.00K $501.33K Reduce
Q1 2026 17.00K $863.60K Hold
Q2 2026 267.13K $18.71M Add
Q3 2026 152.22K $29.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Leonteq Securities AG held MRNA?

Leonteq Securities AG has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Leonteq Securities AG's current position in MRNA?

As of Q3 2026, Leonteq Securities AG holds 152.22K shares of MRNA (MODERNA INC), valued at $29.31M, representing 3.02% of its reported portfolio and ranking #3.

Has Leonteq Securities AG been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Leonteq Securities AG reduced its position in MRNA. The position peaked in Q3 2026 at 152.22K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.